CCR3 and asthma: Besides inhibition of eotaxin-1 and MCP expression by simvastatin, neither IL-13 nor simvastatin treatment changed the expression of other asthma-relevant Th2-type cytokines such as IL-4, CCL5 (RANTES), CCR3, or IL-5Ra.